Other users also viewed these articles
Serum IL-6 is a prognostic biomarker for advanced hepatocellular carcinoma treated with atezolizumab and bevacizumab
Lorenz Kocheise; Jan Kempski; Yunhe Tang; Lorenz Balcar; Victoria Berger; Miriam Tomczak; Joao Gorgulho; Ramsha Masood; Franziska Giehren; Constantin Schmidt; Jan P. Sutter; Thorben W. Fruendt; Francesca Pagani; Sophie Wulf; Julian Kött; Saskia Domanig; Anastasios Giannou; Tanja Bedke; Jöran Lücke; Tao Zhang; Siwen Zhang; Andres Machicote; Ansgar W. Lohse; Marianna Alunni-Fabbroni; Jens Ricke; Najib Ben Khaled; Matthias Pinter; Bernhard Scheiner; Samuel Huber; Johann von Felden; Ignazio Piseddu; Kornelius Schulze;
10.1016/j.aohep.2025.102138
Pancreatic involvement and its prognostic impact in acute-on-chronic liver failure
Georg Kramer; Vlad Taru; Benedikt Simbrunner; Lorenz Balcar; Nina Dominik; Benedikt Silvester Hofer; Lukas Hartl; Mathias Jachs; Georg Semmler; Christian Sebesta; Paul Thöne; Marlene Hintersteininger; Mathias Schneeweiss-Gleixner; Philipp Schwabl; Michael Trauner; Mattias Mandorfer; Thomas Reiberger;
10.1016/j.aohep.2025.102165